The impact of cryoprotectant exposure time on post-thaw viability of autologous and allogeneic hematopoietic stem cells and leukocyte subpopulations

1 FACT-JACIE International Standards for Hematopoietic Cellular Therapy. Product Collection, Processing, and Administration. Eight edition. https://www.ebmt.org/jacie-standards; last access date January 20, 2023. Search in Google Scholar

2 P. Wuchter, Processing, Cryopreserving and Controlling the Quality of HSCs, in The EBMT Handbook Hematopoietic Stem Cell Transplantation and Cellular Therapies (Eds. E. Carreras, C. Dufour, M. Mohtyand, N. Krögel), European Society for Blood and Marrow Transplantation 2019, pp.127–130. Search in Google Scholar

3 European Society for Blood and Marrow Transplantation. Coronavirus disease COVID-19: EBMT recommendations update April 21, 2020; https://www.ebmt.org/sites/default/files/2020-04/EBMT_COVID-19-guidelines_v.7.1%282020-04-21%29.pdf; last access date January 12, 2023. Search in Google Scholar

4 National Marrow Donor Program: BeTheMatch. Donor Product Cryopreservation: updated March 23, 2020; https://www.ebmt.org/sites/default/files/2020-04/EBMT_COVID-19-guidelines_v.7.1%282020-04-21%29.pdf; last access date January 12, 2023. Search in Google Scholar

5 K. Hornberger, G. Yu, D. McKenna and A. Hubel, Cryopreservation of hematopoietic stem cells: Emerging assays, cryoprotectant agents, and technology to improve outcomes, Transfus. Med. Hemother. 46(3) (2019) 188–196; https://doi.org/10.1159/000496068 Search in Google Scholar

6 V. Fisher, H. Khuu, V. David-Ocampo, K. Byrne, S. Pavletic, M. Bishop, D. H. Fowler, A. J. Barrett and D. F. Stroncek, Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation, Transfusion 54(4) (2014) 1088–1092; https://doi.org/10.1111/trf.12428 Search in Google Scholar

7 C. Berens, A. Heine, J. Müller, S. A. Held, K. Mayer, P. Brossart, J. Oldenburg, B. Pötzsch, D. Wolf and H. Rühl, Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products, Cytotherapy 18(10) (2016) 1325–1331; https://doi.org/10.1016/j.jcyt.2016.06.014 Search in Google Scholar

8 H. Yang, J. P. Acker, M. Cabuhat and L. E. McGann, Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation, Bone Marrow Transplant. 32(10) (2003) 1021–1026; https://doi.org/10.1038/sj.bmt.1704247 Search in Google Scholar

9 International Organization for Standardization (ISO). EN ISO 15189 – Medical laboratories – Requirements for quality and competence, 4^th ed, Geneva, Switzerland: ISO; 2022. Search in Google Scholar

10 R. Gomez-Rioja, A. Von Meyer, M. Cornes, S. Costelloe, P. Vermeersch, A. M. Simundic, M. Nybo, G. S. Baird, G. B. B. Kristensen and J. Cadamuro, European Federation of Clinical Chemistry, Laboratory Medicine (EFLM) Working Group Preanalytical Phase (WG-PRE) Recommendation for the design of stability studies on clinical specimens, Clin. Chem. Lab. Med. 2023; Epub ahead of print; https://doi.org/10.1515/cclm-2023-0221 Search in Google Scholar

11 J. W. Gratama, J. Kraan, M. Keeney, D. R. Sutherland, V. Granger and D. Barnett, Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study, Cytotherapy 5(1) (2003) 55–65; https://doi.org/10.1080/14653240310000083 Search in Google Scholar

12 B. Mfarrej, J. Gaude, J. Couquiaud, B. Calmels, C. Chabannon and C. Lemarie, Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products, Cytotherapy 23(1) (2021) 77–87; https://doi.org/10.1016/j.jcyt.2020.06.005 Search in Google Scholar

13 Y. H. Lee, H. Koh, E. Nam and Y. J. Kim, Cryopreserved cord blood mononuclear cells in DMSO are healthy for at least 6 hours after thawing, Transfus. Apher. Sci. 59(1) (2020) Article ID 102603; https://doi.org/10.1016/j.transci.2019.06.028 Search in Google Scholar

14 L. J. Fry, S. Querol, S. G. Gomez, S. McArdl, R. Rees and J. A. Madrigal, Assessing the toxic effects of DMSO on cord blood to determine exposure time limits and the optimum concentration for cryopreservation, Vox Sang. 109(2) (2015)181–190; https://doi.org/10.1111/vox.12267 Search in Google Scholar

15 L. Huang, G. Q. Song, Y. Wu, Y. J. Wang and Z. M. Sun, Optimal length of time of cryopreserved umbilical cord blood infusion after thawing, Hematology 19(2) (2014) 73–99; https://doi.org/10.1179/1607845413Y.0000000101 Search in Google Scholar

16 Z. Shu, S. Heimfeld and D. Gao, Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion, Bone Marrow Transplant. 49(4) (2014) 469–476; https://doi.org/10.1038/bmt.2013.152 Search in Google Scholar

17 J. Valtola, V. Varmavuo, A. Ropponen, A. Nihtinen, A. Partanen, K. Vasala, P. Lehtonen, K. Penttilä, M. Pyörälä, T. Kuittinen, R. Silvennoinen, T. Nousiainen, J. Pelkonen, P. Mäntymaa and E. Jantunen. Blood graft cellular composition and posttransplant recovery in non-Hodgkin’s lymphoma patients mobilized with or without plerixafor: a prospective comparison, Transfusion 55 (10) (2015) 2358–2368; https://doi.org/10.1111/trf.13170.2015; 55:2358-68 Search in Google Scholar

18 A. Turunen, A. Partanen, J. Valtola, A. Ropponen, T. Siitonen, O. Kuittinen, H. Kuitunen, M. Putkonen, M. Sankelo, L. Keskinen, E. R. Savolainen, M. Pyörälä, T. Kuittinen, R. Silvennoinen, K. Penttilä, A. Sikiö, K. Vasala, P. Mäntymaa, J. Pelkonen, V. Varmavuo, E. Jantunen, CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin’s lymphoma patients: results of the prospective multicenter GOA study, Transfusion 60 (7) (2020) 1519–1528; https://doi.org/10.1111/trf.15820 Search in Google Scholar

19 C. C. Pedrosa de Lira de Morais, J. Dias Alves Pint, K. Wagner de Souza, M. Izu, L. Fernando da Silva Bouzas and F. Henrique Paraguassú-Braga, Validation of the single-platform ISHAGE protocol for enumeration of CD34+ hematopoietic stem cells in umbilical cord blood in a Brazilian center, Hematol. Transfus. Cell Ther. 44(1) (2022) 49–55; https://doi.org/10.1016/j.htct.2020.09.151 Search in Google Scholar

20 J. Fernandez-Sojo, R. Horton, J. Cid, C. Azqueta, A. Garcia-Buendia, E. Valdivia, L. Martorell, N. Rubio-Lopez, M. Codinach, G. Aran, J. Marsal, A. Mussetti, R. Martino, C. Diaz-de-Heredia, C. Ferra, D. Valcarcel, M. Linares, A. Ancochea, E. García-Rey, N. García-Muñoz, L. Medina, E. Carreras, J. Villa, M. Lozano, D. Gibson and S. Querol, Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry, Bone Marrow Transplant. 57(10) (2022)1531–1538; https://doi.org/10.1038/s41409-022-01750-2 Search in Google Scholar

21 G. Fritsch, N. Frank, J. Dmytrus, C. Frech, H. Pichler, V. Witt, R. Geyeregger, D. Scharner, D. Trbojevic, E. Zipperer, D. Printz and N. Worel, Relevance of flow cytometric enumeration of post-thaw leucocytes: influence of temperature during cell staining on viable cell recovery, Vox Sang. 111(12) (2016) 187–196; https://doi.org/10.1111/vox.12398 Search in Google Scholar